Bo is a physician entrepreneur and currently an associate with Panacea Venture. He focuses on early-stage biotech investment opportunities and has interests in longevity and regenerative medicine. Bo is a board observer for Actym Therapeutics and Biograph 55, and has an operating role in Feng Biosciences. Prior to joining Panacea, Bo launched a collaboration with Utah Cancer Specialists to provide telemedicine services to patients in Wuhan, China. He co-founded Peng Consulting Group, LLC and worked as a health care consultant to develop strategies for US/China cross-border business ventures. Bo was also co-founder and CEO of Beauvida Personal Care, a cosmetic product company and prior to that was VP of sales and marketing of ARCSino, Inc, the North America operations for ARC Medical, a China-based manufacturer of surgical devices. Bo received his B.A. in Health and Societies from the University of Pennsylvania. He was a Fulbright Scholar, conducting research on obstructive sleep apnea and acupuncture in Wuhan, China and later received his M.D. from the Warren Alpert Medical School of Brown University.